Leukemic retinopathy, a rare entity: A case report

Authors

DOI:

https://doi.org/10.3126/ajms.v12i9.37021

Keywords:

Chronic myelogenous leukemia, leukemic retinopathy

Abstract

Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a myeloproliferative disorder characterized by increased proliferation of the granulocytic cell line without the loss of their capacity to differentiate. Consequently, the peripheral blood cell profile shows an increased number of granulocytes and their immature precursors, including occasional blast cells. CML accounts for 20% of all leukemias affecting adults. Retinal lesions are the most common ocular manifestation of leukemia. They are found most often in adults and in patients with myeloid leukemia. Despite the significant efforts made by different groups to optimize treatment and outcome, there are still unmet needs and unanswered questions. Ophthalmologic manifestations are among the therapeutic challenge. Here we present a case of CML (chronic phase) with ophthalmologic manifestations as initial presentation, trying to shed light on this important type of presentation.

Downloads

Download data is not yet available.
Abstract
129
PDF
205

Downloads

Published

2021-09-01

How to Cite

Gupta, A. K., Basnet, R., Yadav, R. D., & Singh, S. (2021). Leukemic retinopathy, a rare entity: A case report. Asian Journal of Medical Sciences, 12(9), 160–165. https://doi.org/10.3126/ajms.v12i9.37021

Issue

Section

Case Reports